RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer

Padraic Flavin, Aisling Redmond, Jean McBryan, Sinead Cocchiglia, Paul Tibbitts, Patrick Fahy-Browne, Elaine Kay, Achim Treumann, Kilian Perrem, Marie McIlroy, Arnold D.K. Hill, Leonie S. Young

Research output: Contribution to journalArticlepeer-review

Abstract

Human cancers utilise telomerase to maintain telomeres and prohibit cell senescence. Human telomerase reverse transcriptase (hTERT), an essential component of this complex, is regulated at the level of gene transcription. Using SILAC-proteomic analysis and molecular studies, we identified the AAA+ ATPase, RuvBl2 as a transcriptional regulator of hTERT and established that this regulation is through cooperation with Ets-2. In colon cancer patients, nuclear expression of RuvBl2 associated with nuclear expression of hTERT, pEts2 and advanced nodal disease (P < 0.01, P = 0.05 and P = 0.03 respectively, n = 170). These data firmly implicate RuvBl2 in Ets2 mediated regulation of hTERT in colon cancer which has functional and clinical consequences.

Original languageEnglish
Pages (from-to)2537-2544
Number of pages8
JournalFEBS Letters
Volume585
Issue number15
DOIs
Publication statusPublished - 4 Aug 2011
Externally publishedYes

Keywords

  • c-Myc
  • Colon cancer
  • hTERT
  • RuvBl2

Fingerprint

Dive into the research topics of 'RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer'. Together they form a unique fingerprint.

Cite this